A new Mayo Clinic study has found that applying artificial intelligence (AI) to an electrocardiogram (EKG) test results in an easy early indicator of asymptomatic left ventricular dysfunction, which is a precursor to heart failure.
The Mayo research team found that the AI/EKG test accuracy compares favorably with other common screening tests, such as mammography for breast cancer. The findings were published in the journal Nature Medicine.
